Yarrow Bioscience, Inc. — Form SCHEDULE 13D/A
Filed July 29, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
AI Biotechnology LLC (a subsidiary of Access Industries, Inc.) filed an amended Schedule 13D/A on July 29, 2026 regarding beneficial ownership in Yarrow Bioscience, Inc. The filing document itself contains no substantive disclosures of share counts, percentages, dollar amounts, or changes to beneficial ownership — only filing metadata and entity identifiers are present. The specific details of what ownership position was amended and to what level cannot be determined from this filing.
Why this rating
Amendment alone is routine; substantive details absent from provided text. Cannot assess material impact without actual ownership percentages or share counts disclosed.
See more from July 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.